Sunlight affects more than your skin.
Dr. David Bearss explains how sunlight exposure is tied to serotonin levels and why reduced exposure is linked to seasonal affective disorder.
Your body expects sunlight.
🎧 Watch or listen now: https://t.co/LJuKclnZTi
For decades, we’ve been told that the healthiest approach is to minimize sun exposure whenever possible. But emerging research suggests the relationship between sunlight and health may be more nuanced than many of us realize.
In the latest episode of the Good Medicine Podcast, my brother, Dr. Jeremiah Bearss, and I explore the science behind sunlight and its impact on human health.
We discuss:
🔹 Research showing increased all-cause mortality among individuals with very low sun exposure
🔹 How sunlight influences serotonin production, mood, and overall well-being
🔹 The potential connection between reduced light exposure and Seasonal Affective Disorder (SAD)
🔹 Why finding the right balance between sun protection and healthy exposure may be important for long-term health
The goal isn’t to encourage excessive sun exposure or ignore the risks of skin cancer. Rather, it’s to have a thoughtful discussion about how sunlight affects our biology and whether complete avoidance may have unintended consequences.
As with many things in medicine, the answer may not be found at either extreme—it may be found in balance.
Watch the full episode here:
https://t.co/VYP8tR0H7d
Researchers found women who avoided sunlight had roughly double the all-cause mortality risk.
In low sunlight environments, the increased risk was compared to smoking.
That completely changes how we should think about sun exposure.
🎧 Episode drops tomorrow.
🧬 Halia Therapeutics will present final Phase 2 results for ofirnoflast (HT-6184) in patients with lower-risk myelodysplastic syndrome at the EHA 2026 Congress in Stockholm. 🚀 More 👉 https://t.co/nsHKHVGtAS
#BioUtah#HaliaTherapeutics#LifeSciencesElevated#UtahInnovation
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer https://t.co/aS16TCfUIg
If you were born in the 90s, your risk of colon cancer is 4x higher than previous generations.
That’s not a small trend. That’s a massive shift in a very short period of time.
🎧 Episode drops tomorrow.
Two graduates, one proud dad. 🎓
Celebrating my son and daughter-in-law as they close this chapter at BYU and step into the "real world." Watching them earn their degrees side by side, one from the College of Life Sciences and one from the College of Computational, Mathematical, and Physical Sciences, has been such a joy. The future is bright for these two, and I couldn't be prouder. Go out and do good things, you two. 💙
#BYUGrad #ProudDad #Classof2026
A new study found a 9x increase in cancer diagnosis.
Dr David Bearss breaks down findings from the Karolinska Institute and what “incident anemia” could signal in the short term.
🎧 Episode drops tomorrow.
What if even partial success Alzheimer's treatment could change everything?
Dr. Brendon Boot shares why early results give reason for optimism and how upcoming clinical work could reshape the future of neurodegenerative disease.
🎧 Watch or listen now: https://t.co/LJuKclnZTi
One of the most important models for Alzheimer’s research is not in a lab. It is in people’s homes.
Dr. Brendon Boot explains why dogs that naturally develop Alzheimer’s are helping researchers better understand the disease and test new therapies.
https://t.co/LJuKclnZTi
Alzheimer’s is no longer being defined by memory loss.
Dr. Brendon Boot explains how the field has shifted toward understanding the biological changes in the brain long before symptoms appear and why that matters for treatment.
🎧 Episode drops tomorrow.
What if pain could be turned down at the source?
Josh Miller talks about how BIOS technology may be able to interrupt electrical pain signals in the body, creating new possibilities for pain management without relying on traditional approaches.
Watch the full episode now.